BioCorRx (BICX) EBT Margin (2011 - 2026)
BioCorRx (BICX) posted EBT Margin of 400.81% for Q1 2026, down 131.21% sequentially from 173.35% in Q4 2025, and up 23060.0% YoY from N/an in Q1 2025.
Powered by 
Analysis
BioCorRx (BICX) EBT Margin (2011 - 2026) Analysis & Trends
BioCorRx has reported EBT Margin for 16 years, with the latest figure at 400.81% in Q1 2026.
- Quarterly EBT Margin rose 23060.0% year-over-year to 400.81% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 208.63% (up 326501.0% YoY) and the FY2025 annual result came in at 440.11%, up 6755861.0% from the prior year.
- EBT Margin retreated to 400.81% in Q1 2026 per BICX's latest filing, from 173.35% in the prior quarter.
- Over five years, EBT Margin peaked at 0.45% in Q3 2025 and troughed at 34184.06% in Q1 2024.
- A 5-year average of 6851.72% and a median of 2498.85% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2024 and 2025: EBT Margin sank 3168521 bps in 2024, then jumped 3355265 bps in 2025.
- Over 5 years, EBT Margin stood at 1403.25% in 2022, then slumped by 265 bps to 5116.74% in 2023, then sank by 496 bps to 30506.7% in 2024, then jumped by 99 bps to 173.35% in 2025, then plunged by 131 bps to 400.81% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 400.81%, 173.35%, and 0.45% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 12.33% |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 23.81% |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 16.38% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 12.24% |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 10.33% |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 9.28% |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 13.57% |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 7.41% |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 14.74% |
| 10 | BioCorRx | 3.46 Mn | 3.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -400.81% |
| Dec 31, 2025 | 309.95% |
| Sep 30, 2025 | -127.72% |
| Jun 30, 2025 | -772.72% |
| Mar 31, 2025 | -631.41% |
| Jun 30, 2024 | -30,506.70% |
| Mar 31, 2024 | -34,184.06% |
| Dec 31, 2023 | -5,116.74% |
| Sep 30, 2023 | -8,549.51% |
| Jun 30, 2023 | -4,703.58% |
| Mar 31, 2023 | -2,498.85% |
| Dec 31, 2022 | -1,403.25% |
| Sep 30, 2022 | -1,006.98% |
| Jun 30, 2022 | -8,235.34% |
| Mar 31, 2022 | -4,605.67% |
| Dec 31, 2021 | -9,323.26% |
| Sep 30, 2021 | -15,461.46% |
| Jun 30, 2021 | -6,755.98% |
| Mar 31, 2021 | -15,646.61% |
| Dec 31, 2020 | -4,071.05% |